97 related articles for article (PubMed ID: 11589099)
21. Lithocholylcholine, a bile acid/acetylcholine hybrid, is a muscarinic receptor antagonist.
Cheng K; Khurana S; Chen Y; Kennedy RH; Zimniak P; Raufman JP
J Pharmacol Exp Ther; 2002 Oct; 303(1):29-35. PubMed ID: 12235229
[TBL] [Abstract][Full Text] [Related]
22. Effect of M2 muscarinic receptor blockade in rats with haloperidol-produced catatonic syndrome.
Dagaev SG; Fil'ko OA; Kubarskaya LG; Khrabrova AV; Mukovskii LA; Glukhova RI; Sanotskii VI; Dolgo-Saburov VB
Bull Exp Biol Med; 2004 May; 137(5):468-70. PubMed ID: 15455120
[TBL] [Abstract][Full Text] [Related]
23. Effects of dextromethorphan on dopamine dependent behaviours in rats.
Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ
Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
[TBL] [Abstract][Full Text] [Related]
24. Effect of M4-cholinoceptor blockade on haloperidol-produced catatonic syndrome in rats.
Dagaev SG; Kosmachev AB; Filko OA; Kubarskaya LG; Khrabrova AV; Beliaev VA; Podosinovikova NP; Libman NM; Sanotskii VI; Dolgo-Saburov VB
Bull Exp Biol Med; 2004 Feb; 137(2):152-4. PubMed ID: 15273762
[TBL] [Abstract][Full Text] [Related]
25. Atropine acts in the ventral striatum to reduce raclopride-induced catalepsy.
Alcock SJ; Hemsley KM; Crocker AD
Eur J Pharmacol; 2001 Jul; 424(3):179-87. PubMed ID: 11672560
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
Zazpe A; Artaiz I; Innerárity A; Del Olmo E; Castro E; Labeaga L; Pazos A; Orjales A
Neuropharmacology; 2006 Jul; 51(1):129-40. PubMed ID: 16643965
[TBL] [Abstract][Full Text] [Related]
27. Effects of buspirone on dopamine dependent behaviours in rats.
Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
[TBL] [Abstract][Full Text] [Related]
28. Loss of anti-cataleptic effect of scopolamine in mice lacking muscarinic acetylcholine receptor subtype 4.
Karasawa H; Taketo MM; Matsui M
Eur J Pharmacol; 2003 May; 468(1):15-9. PubMed ID: 12729838
[TBL] [Abstract][Full Text] [Related]
29. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
Yanahashi S; Hashimoto K; Hattori K; Yuasa S; Iyo M
Brain Res; 2004 Jun; 1011(1):84-93. PubMed ID: 15140647
[TBL] [Abstract][Full Text] [Related]
30. Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function.
Eglen RM
Auton Autacoid Pharmacol; 2006 Jul; 26(3):219-33. PubMed ID: 16879488
[TBL] [Abstract][Full Text] [Related]
31. Muscarinic agonist-mediated heterologous desensitization in isolated ileum requires activation of both muscarinic M2 and M3 receptors.
Griffin MT; Matsui M; Shehnaz D; Ansari KZ; Taketo MM; Manabe T; Ehlert FJ
J Pharmacol Exp Ther; 2004 Jan; 308(1):339-49. PubMed ID: 14563784
[TBL] [Abstract][Full Text] [Related]
32. [Effect of biotransformation on the receptor selectivity of muscarinic antagonists in vivo].
Kosmachev AB; Titkova TA; Fil'ko OA; Libman NM
Eksp Klin Farmakol; 2000; 63(4):13-6. PubMed ID: 11022298
[TBL] [Abstract][Full Text] [Related]
33. [Characteristics of effects of acetylene amino alcohols M-cholinoreceptor blockers on the dopaminergic system in Daphnia magna].
Kosmachev AB; Tonkopiĭ VD; Podosinovikova NP; Zagrebin AO; Evdokimova EA; Libman NM; Petrov VV; Dolgo-Saburov VB
Eksp Klin Farmakol; 2000; 63(6):15-7. PubMed ID: 11202502
[TBL] [Abstract][Full Text] [Related]
34. MTEP, a new selective antagonist of the metabotropic glutamate receptor subtype 5 (mGluR5), produces antiparkinsonian-like effects in rats.
Ossowska K; Konieczny J; Wolfarth S; Pilc A
Neuropharmacology; 2005 Sep; 49(4):447-55. PubMed ID: 15919101
[TBL] [Abstract][Full Text] [Related]
35. Expression of muscarinic receptor subtypes in salivary glands of rats, sheep and man.
Ryberg AT; Warfvinge G; Axelsson L; Soukup O; Götrick B; Tobin G
Arch Oral Biol; 2008 Jan; 53(1):66-74. PubMed ID: 17825245
[TBL] [Abstract][Full Text] [Related]
36. Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.
Böhme TM; Keim C; Kreutzmann K; Linder M; Dingermann T; Dannhardt G; Mutschler E; Lambrecht G
J Med Chem; 2003 Feb; 46(5):856-67. PubMed ID: 12593665
[TBL] [Abstract][Full Text] [Related]
37. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
Khisti RT; Deshpande LS; Chopde CT
Psychopharmacology (Berl); 2002 May; 161(2):120-8. PubMed ID: 11981591
[TBL] [Abstract][Full Text] [Related]
38. Regulation of glutamate release from primary afferents and interneurons in the spinal cord by muscarinic receptor subtypes.
Zhang HM; Chen SR; Pan HL
J Neurophysiol; 2007 Jan; 97(1):102-9. PubMed ID: 17050831
[TBL] [Abstract][Full Text] [Related]
39. Effect of estrogen on muscarinic acetylcholine receptor expression in rat myometrium.
Abdalla FM; Maróstica E; Picarelli ZP; Abreu LC; Avellar MC; Porto CS
Mol Cell Endocrinol; 2004 Jan; 213(2):139-48. PubMed ID: 15062561
[TBL] [Abstract][Full Text] [Related]
40. Muscarinic (M) receptors in coronary circulation: gene-targeted mice define the role of M2 and M3 receptors in response to acetylcholine.
Lamping KG; Wess J; Cui Y; Nuno DW; Faraci FM
Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1253-8. PubMed ID: 15130910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
